
Navigating Transition Periods in Government: A Closer Look at the NIH Pause
January 26, 2025/by Ayal Ronen
Formation Venture Engineering – FreeMind Elite
January 6, 2025/by Ayal Ronen
New England Hemolytics – FreeMind Elite
January 6, 2025/by Ayal Ronen
BioVie – FreeMind Elite
January 6, 2025/by Ayal Ronen
Nemysis – FreeMind Elite
January 6, 2025/by Ayal Ronen
4J Therapeutics – FreeMind Elite
January 6, 2025/by Ayal Ronen
NIH Funding during the first Trump Administration; Driving Growth in Non-Basic Research and Supporting the Life Sciences Industry
December 18, 2024/by Ayal Ronen
4J Therapeutics Secures Major BARDA Contract
November 6, 2024/by Ayal Ronen
Grant Tips & Tricks: Straight from the FreeMind Group Experts
October 10, 2024/by Ayal Ronen
LSX Nordic Congress, October 8-9, 2024, Copenhagen, Denmark
September 29, 2024/by Ayal Ronen
Cell & Gene on the Mesa, October 7-9, 2024, Phoenix, AZ
September 29, 2024/by Ayal Ronen
LSX RNA Leaders, September 4-5, 2024, San Diego
July 24, 2024/by Ayal RonenSearch
Recent Posts
- RESI Europe, April 1, 2025, BarcelonaMarch 26, 2025 - 12:02 pm
- BioTrinity, April 1-2, 2025, LondonMarch 26, 2025 - 11:59 am
- Sachs Associates European Life Sciences CEO ForumMarch 26, 2025 - 11:55 am
- AngloNordic, April 2-3, 2025 in LondonMarch 26, 2025 - 11:50 am
- LSX Nordic Congress, May 20-21, 2025, NorwayMarch 26, 2025 - 11:45 am